Profile data is unavailable for this security.
About the company
Lipidor AB is a Sweden-based drug delivery company focusing on topical medication. The Company is focused to develop, patent and commercialize formulation concepts and technologies based on lipids. The Company develops product concepts based on AKVANO technology, which represents a dosage form that creates a lipid layer on the skin surface for effective delivery of drugs and skin care treatment. The Company’s cooperation partners include Cerbios-Pharma, which specializes in the development and manufacturing of chemical and biological active pharmaceutical ingredients (APIs), and Aurena Laboratories AB, a manufacturer of bag-on-valve aerosol sprays for the pharmaceutical and medical device industry.
- Revenue in SEK (TTM)77.00k
- Net income in SEK-11.49m
- Incorporated2009
- Employees--
- LocationLipidor ABSvardvagen 13DANDERYD 182 33SwedenSWE
- Websitehttps://www.lipidor.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XP Chemistries AB | 663.69k | -8.04m | 4.67m | 2.00 | -- | 0.1818 | -- | 7.04 | -0.2846 | -0.2846 | 0.0213 | 0.275 | 0.023 | 0.2084 | 5.99 | 331,845.00 | -27.79 | -- | -29.36 | -- | 50.57 | -- | -1,211.24 | -- | 5.79 | -- | 0.00 | -- | -37.14 | -- | -1.55 | -- | -- | -- |
| QuiaPEG Pharmaceuticals Holding AB | 0.00 | -16.52m | 5.10m | 8.00 | -- | 0.3346 | -- | -- | -3.51 | -3.51 | 0.00 | 0.2047 | 0.00 | -- | -- | -- | -50.53 | -95.67 | -100.54 | -207.86 | -- | 262.59 | -- | -5,002.50 | -- | -15.34 | 0.00 | -- | -- | -- | 17.75 | -- | 47.06 | -- |
| European Institute of Science AB | 600.00k | -2.72m | 5.77m | 0.00 | -- | 1.43 | -- | 9.62 | -4.25 | -4.25 | 0.9397 | 2.98 | 0.1728 | 0.8479 | 8.63 | -- | -78.21 | -93.04 | -82.77 | -103.14 | 62.33 | 67.01 | -452.67 | -518.82 | 10.54 | -- | -- | -- | 13.69 | 8.54 | 0.4062 | -- | -- | -- |
| 2cureX AB | 155.00k | -30.82m | 5.91m | -- | -- | 0.432 | -- | 38.16 | -1.75 | -1.75 | 0.0088 | 0.7777 | 0.0048 | -- | 0.0838 | -- | -95.89 | -38.21 | -108.66 | -43.48 | -6,889.68 | -22,153.06 | -19,883.23 | -38,685.30 | -- | -46.08 | -- | -- | 72.22 | -- | -3.52 | -- | -- | -- |
| Bio Vitos Pharma AB | 2.98m | -12.87m | 6.01m | 1.00 | -- | 1.56 | 11.71 | 2.02 | -0.2547 | -0.2547 | 0.0533 | 0.1119 | 0.0989 | 0.00 | 5.38 | 2,983,990.00 | -42.63 | -31.11 | -44.50 | -32.92 | 100.00 | -- | -431.21 | -1,026.76 | 4.27 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| Lipidor AB | 77.00k | -11.49m | 6.81m | -- | -- | -- | -- | 88.44 | -0.3964 | -0.3964 | 0.0027 | -0.3223 | 0.0084 | -- | 5.31 | -- | -124.54 | -59.41 | -- | -75.10 | -- | -- | -14,916.88 | -643.36 | -- | -- | -- | -- | 73.33 | -20.33 | 72.24 | -- | -- | -- |
| Stayble Therapeutics AB | 0.00 | -23.74m | 8.41m | 3.00 | -- | 0.5092 | -- | -- | -0.9492 | -0.9492 | 0.00 | 0.5204 | 0.00 | -- | -- | 0.00 | -116.21 | -78.64 | -141.76 | -95.58 | -- | -- | -- | -- | -- | -- | 0.049 | -- | -- | -- | 3.22 | -- | -- | -- |
| Amniotics AB (publ) | 0.00 | -30.87m | 10.11m | 6.00 | -- | 0.6454 | -- | -- | -0.0374 | -0.0374 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -112.25 | -101.09 | -362.71 | -149.92 | -- | -- | -- | -- | 1.12 | -16.17 | -- | -- | -- | -- | 35.75 | -- | -- | -- |
| Carbiotix AB (publ) | 1.47m | -13.48m | 11.50m | 10.00 | -- | 0.1672 | -- | 7.85 | -0.302 | -0.302 | 0.0324 | 0.3817 | 0.0586 | -- | 2.36 | 146,552.00 | -53.88 | -49.38 | -64.85 | -55.50 | 235.45 | 574.69 | -919.76 | -1,828.86 | -- | -76.28 | 0.1384 | -- | 259.56 | -12.04 | -10.02 | -- | 13.64 | -- |
| Eurocine Vaccines AB | 5.00k | -15.06m | 12.09m | 3.00 | -- | -- | -- | 2,418.05 | -0.1472 | -0.1472 | 0.00005 | -0.0018 | 0.0007 | -- | 0.002 | -- | -199.76 | -83.17 | -323.19 | -97.89 | -199,780.00 | -- | -301,180.00 | -- | -- | -- | -- | -- | -- | -- | 8.95 | -- | -- | -- |
| Aptahem AB | 32.00k | -11.11m | 13.36m | -- | -- | 0.1306 | -- | 417.60 | -0.0497 | -0.0497 | 0.0001 | 0.2266 | 0.0005 | -- | 0.0738 | -- | -16.76 | -39.26 | -19.47 | -44.19 | 4,623.59 | -- | -34,727.72 | -- | -- | -10.17 | 0.0847 | -- | -- | -- | -25.36 | -- | -- | -- |
| AegirBio AB | 99.00k | -367.00m | 15.84m | 1.00 | -- | 1.77 | -- | 160.00 | -24.31 | -24.31 | 0.0047 | 0.2895 | 0.0004 | 2.00 | 0.0207 | -- | -163.02 | -- | -171.79 | -- | -24,398.99 | -- | -370,710.10 | -- | 2.53 | -27.27 | 0.8209 | -- | -87.16 | -- | -292.98 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to Lipidor AB's reporting currency: Swedish Krona SEK
